Senseonics Holdings Inc (SENS) Short Interest Up 3.5% in August
Senseonics Holdings Inc (NYSEAMERICAN:SENS) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 14,340,210 shares, an increase of 3.5% from the August 15th total of 13,861,627 shares. Based on an average trading volume of 1,501,759 shares, the days-to-cover ratio is presently 9.5 days. Currently, 15.9% of the company’s stock are short sold.
Shares of NYSEAMERICAN SENS opened at $4.50 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics has a 52-week low of $2.36 and a 52-week high of $5.29.
Senseonics (NYSEAMERICAN:SENS) last announced its quarterly earnings results on Wednesday, August 8th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.09). The company had revenue of $3.62 million for the quarter, compared to analysts’ expectations of $3.87 million. Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The business’s revenue was up 345.1% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.12) EPS. research analysts forecast that Senseonics will post -0.54 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently made changes to their positions in SENS. Tibra Equities Europe Ltd purchased a new stake in shares of Senseonics during the 1st quarter valued at about $546,000. Element Capital Management LLC purchased a new stake in shares of Senseonics during the 1st quarter valued at about $309,000. Millennium Management LLC boosted its holdings in shares of Senseonics by 43.5% during the 1st quarter. Millennium Management LLC now owns 1,387,566 shares of the company’s stock valued at $4,163,000 after acquiring an additional 420,358 shares during the last quarter. Bank of Montreal Can purchased a new stake in shares of Senseonics during the 2nd quarter valued at about $1,030,000. Finally, Broadview Advisors LLC purchased a new stake in shares of Senseonics during the 2nd quarter valued at about $2,774,000. 30.66% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages recently commented on SENS. Raymond James increased their price objective on shares of Senseonics from $4.00 to $6.00 and gave the company an “outperform” rating in a research report on Friday, June 22nd. BTIG Research reissued a “buy” rating and set a $6.00 price objective on shares of Senseonics in a research report on Thursday, August 9th. Craig Hallum began coverage on shares of Senseonics in a research report on Monday, June 11th. They set a “buy” rating and a $7.00 price objective on the stock. Dougherty & Co began coverage on shares of Senseonics in a research report on Friday, August 24th. They set a “buy” rating and a $6.00 price objective on the stock. Finally, Canaccord Genuity reissued a “buy” rating and set a $5.00 price objective on shares of Senseonics in a research report on Friday, May 18th. Six research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of $6.00.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Further Reading: Understanding Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.